COVID-19 vaccines are generally safe, with most Adverse Events Following Immunisation (AEFIs) being minor and resolving on their own
'Behind every successful woman, there is an understanding man'
iNCOVACC can produce three immune responses, says Bharat Biotech
'iNCOVACC' is priced at Rs 800 for private markets
'The Department will continue to promote and encourage COVID-19 vaccination'
iNCOVACC is now available on CoWIN portal
iNCOVACC approved by govt, to be available in private hospitals
Bharat Biotech condemned the "targeted narrative" against the vaccine
Only 20 per cent of eligible population have taken the booster dose
Only 17% of eligible people received precaution dose till Aug 15
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 2020
Departmental probe recommended against Sagar district immunisation officer
The return to near-normal applied everywhere in Beijing
Covovax has been included on CoWIN portal for inoculation of children aged 12-17 yrs
A dose of Covovax will cost Rs 900 plus GST
Directs Centre to publish data on vaccine trials
The death toll due to COVID-19 climbed to 5,23,693 with 39 more fatalities
Shanghai, on Tuesday, reported 1,606 confirmed locally transmitted Covid-19 cases
West Bengal currently has 288 active coronavirus cases
Covaxin was approved for use on 12-18 age group in December last year
India's R-value, at present, stands at 1.3, the analysis found
City reports 1,009 new cases, one death; positivity rate at 5.7%
632 fresh cases reported on Tuesday; positivity rate at 4.42%
Positivity rate jumps to 7.72%
Positivity rate goes down to 4.21%
Results 1-25 of 729 for Vaccine